Evidence map›Paper›PMID 38739745›Full record

ArticleACS applied materials & interfaces2024

NIR-Responsive Methotrexate-Modified Iron Selenide Nanorods for Synergistic Magnetic Hyperthermic, Photothermal, and Chemodynamic Therapy.

Senthilkumar Thirumurugan, Kayalvizhi Samuvel Muthiah, Yu-Chien Lin, Udesh Dhawan, Wai-Ching Liu, An-Ni Wang, Xinke Liu, Michael Hsiao, Ching-Li Tseng, Ren-Jei Chung

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Senthilkumar ThirumuruganDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), No. 1, Section 3, Zhongxiao East Road, Taipei 10608, Taiwan.
Kayalvizhi Samuvel MuthiahDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), No. 1, Section 3, Zhongxiao East Road, Taipei 10608, Taiwan.
Yu-Chien LinDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), No. 1, Section 3, Zhongxiao East Road, Taipei 10608, Taiwan.ORCID 0000-0003-3290-439X
Udesh DhawanCentre for the Cellular Microenvironment, Division of Biomedical Engineering, James Watt School of Engineering, Mazumdar-Shaw Advanced Research Centre, University of Glasgow, Glasgow G116EW, U.K.
Wai-Ching LiuFaculty of Science and Technology, Technological and Higher Education Institute of Hong Kong, New Territories, Hong Kong 999077, China.
An-Ni WangScrona AG, Grubenstrasse 9, 8045 Zürich, Switzerland.
Xinke LiuCollege of Materials Science and Engineering, Chinese Engineering and Research Institute of Microelectronics, Shenzhen University, Shenzhen 518060, China.ORCID 0000-0002-3472-5945
Michael HsiaoGenomics Research Center, Academia Sinica, Taipei 115, Taiwan.ORCID 0000-0001-8529-9213
Ching-Li TsengGraduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0001-9446-4030
Ren-Jei ChungDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), No. 1, Section 3, Zhongxiao East Road, Taipei 10608, Taiwan.ORCID 0000-0002-0655-3680

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a malignant tumor with a high mortality rate among women. Therefore, it is necessary to develop novel therapies to effectively treat this disease. In this study, iron selenide nanorods (FeSe

Indexed as

Breast NeoplasmsHyperthermia, InducedMethotrexateMice, NudeNanotubesAnimalsCell Line, TumorFemaleHumansInfrared RaysIronMiceMice, Inbred BALB CPhotothermal TherapySelenium CompoundsIronMethotrexateSelenium Compoundsalternating magnetic field (AMF)chemodynamic therapy (CDT)magnetic hyperthermia therapy (MHT)methotrexate (MTX)photothermal therapy (PTT)

Identifiers

PMID38739745
PMCPMC11129116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.